Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +46.80%
#2 Mubarak Mubarak +36.45%
#3 Pons Pons +36.32%
#4 Starpower Starpower +34.59%
#5 Bitway Bitway +31.78%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +31.19%
#7 TENDIES TENDIES +25.97%
#8 Ocean Protocol Ocean Protocol +24.85%
#9 SkyAI SkyAI +24.01%
#10 StonkBroker StonkBroker +21.30%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Celularity Inc. Celularity Inc.

Celularity Inc.

CELU
Classifica tra le azioni #29211
Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to... Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering "off-the-shelf" allogeneic cell therapies, which are developed from placental sources. These innovative treatments are designed to combat a range of serious conditions, including various cancers, immune system dysfunctions, and infectious diseases. The company’s operations are segmented into three distinct areas: Cell Therapy, Degenerative Disease, and BioBanking. Their therapeutic pipeline features several key candidates: CYCART-19, a placental-derived CAR-T therapy, currently in Phase I trials for B-cell malignancies; CYNK-001, an unmodified natural killer (NK) cell also from placental sources, advancing through Phase I trials for acute myeloid leukemia and Phase I/IIa trials for glioblastoma multiforme and COVID-19; and CYNK-101, an allogeneic genetically modified NK cell, which is in Phase I for HER2+ gastric and gastroesophageal cancers. Furthermore, two mesenchymal-like adherent stromal cell candidates, APPL-001 and PDA-002 (both derived from placentas), are in pre-clinical development for Crohn's disease and facioscapulohumeral muscular dystrophy, respectively. In addition to its therapeutic development, Celularity is involved in commercial activities, offering surgical and wound care products like Biovance and Interfyl through sales and licensing agreements. The company also specializes in collecting stem cells from umbilical cords and placentas, providing storage services under its LifebankUSA brand. Founded in 2016, Celularity Inc. maintains its headquarters in Florham Park, New Jersey.
Prezzo delle azioni
$0.7721
Capitalizzazione di mercato
$22.35M
Variazione (1 giorno)
4.81%
Variazione (1 anno)
-78.61%
Paese
US
Scambia Celularity Inc. (CELU)

Categoria

Healthcare
Il prezzo CELU con la capitalizzazione del mercato della B
Celularity Inc. Celularity Inc.
CELU
$0.7721
Capitalizzazione di mercato di Celularity Inc.(CELU)
Capitalizzazione di mercato: $22.35M
A partire dal August 2026, Celularity Inc. ha una capitalizzazione di mercato pari a $22.35M. Questo rende Celularity Inc. la 29211th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Celularity Inc. dal 2019 al 2026
CELU in paragone con la classifica dei più popolari stocks
Il prezzo per CELU Attivo B Capitalizzazione del mercato a B Risultati
Celularity Inc. Celularity Inc.
$183,235 $22.35M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.304T +23,731,903.43%
Celularity Inc. Celularity Inc.
$161,028 $22.35M
Apple Inc. Apple Inc.
AAPL
$4.661T +20,855,700.15%
Celularity Inc. Celularity Inc.
$143,555 $22.35M
Alphabet Inc. Alphabet Inc.
GOOG
$4.155T +18,592,653.98%
Celularity Inc. Celularity Inc.
$124,271 $22.35M
Microsoft Corporation Microsoft Corporation
MSFT
$3.597T +16,095,143.34%
Celularity Inc. Celularity Inc.
$98,291.48 $22.35M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.845T +12,730,308.40%